Cerity Partners LLC United Therapeutics Corp Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Cerity Partners LLC holds 8,886 shares of UTHR stock, worth $3.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,886

Previous 4,881 82.05%

Holding current value

$3.29 Million

Previous $1.55 Million 104.89%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$311.04 - $363.55 $1.25 Million - $1.46 Million	4,005 Added 82.05%	8,886 $3.18 Million
Q2 2024 Aug 13, 2024	SELL	$228.26 - $319.04 $159,782 - $223,328	-700 Reduced 12.54%	4,881 $1.55 Million
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $773,910 - $916,200	3,672 Added 192.35%	5,581 $1.28 Million
Q4 2023 Jan 26, 2024	BUY	$214.88 - $256.94 $410,205 - $490,498	1,909 New	1,909 $419,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $17,030 - $19,338	83 Added 4.43%	1,957 $432,000
Q1 2023 May 11, 2023	SELL	$212.99 - $276.17 $14,909 - $19,331	-70 Reduced 3.6%	1,874 $419,000
Q4 2022 Feb 15, 2023	BUY	$205.95 - $280.43 $400,366 - $545,155	1,944 New	1,944 $540,000
Q1 2020 May 14, 2020	SELL	$79.39 - $115.35 $291,281 - $423,219	-3,669 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $59,907 - $72,935	765 Added 26.34%	3,669 $323,000
Q3 2019 Oct 30, 2019	BUY	$74.85 - $85.99 $598 - $687	8 Added 0.28%	2,904 $232,000
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $9,051 - $14,376	119 Added 4.29%	2,896 $226,000
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $3,643 - $4,312	34 Added 1.24%	2,777 $326,000
Q4 2018 Feb 06, 2019	BUY	$101.4 - $128.73 $76,050 - $96,547	750 Added 37.63%	2,743 $299,000
Q3 2018 Nov 15, 2018	SELL	$113.81 - $129.46 $22,079 - $25,115	-194 Reduced 8.87%	1,993 $255,000
Q2 2018 Aug 15, 2018	SELL	$101.14 - $118.31 $11,428 - $13,369	-113 Reduced 4.91%	2,187 $247,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $246,583 - $349,462	2,300 New	2,300 $258,000
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $235,025 - $299,836	-1,982 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $227,137 - $271,157	1,982	1,982 $232,000

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC United Therapeutics Corp Transaction History